Cargando…
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that represents <5% of all thyroid malignancies and is generally more aggressive than differentiated thyroid cancer. The aim of this study is to provide an update, through review of clinical studies of patients with MTC published between...
Autores principales: | Bartz-Kurycki, Marisa A., Oluwo, Omowunmi E., Morris-Wiseman, Lilah F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511962/ https://www.ncbi.nlm.nih.gov/pubmed/34659736 http://dx.doi.org/10.1177/20420188211049611 |
Ejemplares similares
-
Advancements in the treatment of differentiated thyroid
cancer
por: Stewart, Latoya A., et al.
Publicado: (2021) -
Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021) -
Is eNAMPT/visfatin a potential serum marker of papillary thyroid
cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022) -
Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021) -
Clinical and molecular characterization of thyroid cancer when seen
as a second malignant neoplasm
por: Romanelli, Kristen, et al.
Publicado: (2021)